Evaluación de comorbilidades y pronóstico de la neumonía por COVID-19: revisión de la literatura
DOI:
https://doi.org/10.24265/horizmed.2021.v21n3.15Palabras clave:
Neumonía, Infecciones por coronavirus, MortalidadResumen
La infección por COVID-19 presenta una elevada mortalidad respecto a otros virus respiratorios. En este artículo buscamos definir las comorbilidades que están asociadas a la elevada mortalidad o a las complicaciones que requieren mayor soporte ventilatorio en unidades de cuidados intensivos. Se ha diseñado una búsqueda bibliográfica con respecto a las comorbilidades y/o alteraciones en los exámenes de laboratorio y los estudios radiológicos que se han asociado a la presencia de mortalidad, especialmente en los casos descritos en China.
Descargas
Citas
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91-5.
Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020; 138(5): 575-8.
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors associated with Acute Respiratory Distress Syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7): 1-11.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382: 1708-20.
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. COVID-19 in critically Ill patients in the seattle region - case series. N Engl J Med. 2020; 382(21): 2012-22.
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respir Med. [Internet]. 2020; 8(4): e21.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-9.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-62.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5): 531-8.
Hill MA, Mantzoros C, Sowers JR. Commentary: COVID-19 in patients with diabetes. Metabolism. 2020; 107: 154217.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75(7): 1730-41.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2): 145-51.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7): 1-8.
Peng YD, Meng K, Guan HQ, Leng L, Zhu RR, Wang BY, et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48(00): E004.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5): 475-81.
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5): 846-8.
Centers for Disease Control. Coronavirus Disease 2019 (COVID-19) [Internet]. 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html
Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, et al. Clinical findings of patients with Coronavirus Disease 2019 in Jiangsu Province, China: a retrospective, multi-center study. PLoS Negl Trop Dis. 2020; 14(5): e0008280.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3): 335-7.
Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-42.
World Health Organization. Report of the WHO - China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. 2020. Disponible en: https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020; 323(16): 1612-4.
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382(10): 929-36.
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020; 323(16): 1582-9.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497-506.
Chen C, Chen C, Yang JT, Zhou N, Zhao JP, Wang DW. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48(0): E008.
American College of Cardiology. Troponin and BNP use in COVID-19 [Internet]. 2020. Disponible en: https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnp-use-in-covid19
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395(10223): 507-13.
Luo C, Yao L, Zhang L, Yao M, Chen X, Wang Q, et al. Possible transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a public bath center in Huai’an, Jiangsu Province, China. JAMA Netw Open. 2020; 3(3): e204583.
Chang D, Lin M, Wei L, Xie L, Zhu G, De la Cruz CS, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020; 323(11): 1092-3.
Li L-Q, Huang T, Wang Y-Q, Wang Z-P, Liang Y, Huang T-B, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020; 92(6): 577-83.
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of Coronavirus Disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20(6): 669-77.
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in Coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020; 296(2): E32-40.
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2021 Félix K. Llanos Tejada, Wendy I. Muñoz Taipe, Nataly L. Muñoz Abanto, Gary E. Saavedra Vilchez, Franca M. Sifuentes Peracchio, Daniel R. Somocurcio Rivera, Ricardo A. Escobar Baigorria, Adriana D. Farro Rodriguez, Ivana P. Bravo Osorio, J. Antonio Salas Lopez
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
El contenido de la Revista Horizonte Médico es de libre acceso, de manera gratuita, con el fin de divulgar los trabajos y experiencias desarrolladas en el área biomédica y de salud pública realizados a nivel nacional e internacional, promoviendo la investigación en los diferentes campos de la medicina humana.
La Revista Horizonte Médico mantiene los derechos de autoría, distribución y reproducción de los artículos publicados.
Todos los artículos aceptados y publicados en la Revista Horizonte Médico se distribuyen gratuitamente bajo los términos de la licencia Creative Commons Attribution 4.0 International (CC BY 4.0).
